ArticleThe oncologist2025

Incidence of patient-reported fatigue developing on palbociclib and endocrine therapy for advanced HR+ HER2- breast cancer.

Shadab A Rahman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.